The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

Nutrition in Health and Disease: Implications for Public Health in Russian Federation First Forum on NCD (Non-communicable Disease) Prevention and Healthy.
Key messages Stephen S Lim, et al. Lancet 2007; 370:
CVD risk estimation and prevention: An overview of SIGN 97.
Zhai, Public Health Nutrition, Feb 2002 WHAT IS CHINA DOING IN POLICY-MAKING TO PUSH BACK THE NEGATIVE ASPECTS OF THE NUTRITION TRANSITION? Fengying Zhai.
Epidemiological and nutritional transition in Mexico: rapid increase
Non Communicable Disease
H.I. GHOSH1 Challenges of NCDs in Palestine *** Heidar Abu Ghosh Director of Chronic Diseases Program *** Palestinian Medical Relief Society.
Chapter Twelve Importance of Noncommunicable Disease.
E NHANCING C OMPREHENSIVE HIV C ARE : Addressing Cardiovascular Disease (CVD) and other Noncommunicable Diseases (NCDs) Kwasi Torpey MD PhD MPH FGCP Deputy.
Coronary Heart Disease (CHD): A Disease of Affluence.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
World Health Organization TOWARDS A GLOBAL DIET AND PHYSICAL ACTIVITY STRATEGY APPROACH - PROGRESS - CHALLENGES DEREK YACH EXECUTIVE DIRECTOR NONCOMMUNICABLE.
Fijian Diet – National Nutrition Survey 2004 NCDs – Non-communicable diseases Non-communicable diseases (NCDs) include cardiovascular diseases, diabetes.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Non-communicable diseases David Redfern
Climate change and noncommunicable diseases: the nutrition connection © Samuel Hauenstein Swan PHI satellite event at the High Level Meeting on Non-Communicable.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Noncommunicable Diseases & Health Promotion ICCC4, Seoul | 4 November 2011 | 1 | CV Profiling NCD and their risk factor in WHO Western Pacific Region Cherian.
T.D. Medical College,Alappuzha
World Health Organisation Internship
Bringing Agriculture to the Table September 19, 2011 September 19, Bringing Agriculture to the Table How Agriculture and Food Can Play a Role in.
WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,
Ministry of Health and Population Preventive and Primary Health Care Sector Ministry of Health and Population Preventive and Primary Health Care Sector.
Dr Godfrey Xuereb Team Leader Surveillance and Population-based Prevention Department for the Prevention of NCDs A comprehensive global monitoring framework.
Evidence-based practices for reducing the economic and health burden of chronic disease By Dr. Kenneth Thorpe Kazan, October 10, 2012.
Present NCDI situation in Mongolia
Non-Communicable Diseases Control Program _________________________________ K R Thankappan MD, MPH Additional Professor and Head Achutha Menon Centre.
NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.
Chapter 15 Adolescent Nutrition: Conditions and Interventions
4 th SIDS Meeting, Sao Tome & Principe April |1 | NCDs in the context of the revised Health Promotion Strategy.
NON COMMUNICABLE DISEASES( NCDs) By NSABIMANA Olivier Philemon, B.Pharm. ASEPA / UNR From 19/4-3/5 /2014.
Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)
The Chronic Disease problem in the Caribbean – civil society perspective Twelfth OECS Health Ministers Meeting, 11 th September 2009 Prof. Trevor A. Hassell.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Dr. Corinne Husten Director (Acting), Office on Smoking and Health The Global Tobacco Epidemic.
Dr. Rohit A, Dr Balu P S Public Health Specialist [ NCD] India
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
Health Statistics and Informatics Non-communicable diseases A global overview.
Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.
Chapter 9: Global Perspectives on Selected Chronic Cardiovascular Diseases Chapter 10: Global Perspectives on Diabetes and Respiratory and Orthopedic Chronic.
Call to action on NCDs: Challenges and Way Forward for Maternal and Child Health Dr. Niloufer Sultan Ali Professor, Family Medicine Aga Khan University,
Innovative ideas to prevent & control Non-Communicable Diseases through Rural Eye Health Intervention Sarangadhar Samal Kalinga Eye Hospital (An unit of.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Linkages between CDs & NCDs: The African context Dr Frank J Mwangemi ICASA 2011: 5 th December 2011 Addis Ababa, Ethiopia.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
An Overview of the Burden of Non- Communicable Diseases (NCDs) Dr Sylvia J Anie Director Social Transformation Programmes Division (Education, Health,
Economic and Social Aspects of NCDs SDE Seminar Series/PAHO 25 April, 2012 Rachel Nugent.
Cardiovascular Risk: A global perspective
Nick Banatvala & Pascal Bovet
Non-communicable diseases (NCDs) include:
Chronic NCDs in Sri Lanka : Policy to Public Health approaches
Outlines towards National NCDs Prevention and Control Strategy
DR GHULAM NABI KAZI WHO Country Office Pakistan
Projected global distribution of total deaths (58 million) by major cause, 2005 Kathleen Strong et al, Lancet 2005; 366: 1578–82.
Non-Communicable Diseases Risk Factors Survey in Georgia
Prevention and Control of Noncommunicable Diseases
prevention and control of non communicable diseases in Iraq
Noncommunicable diseases
Non-communicable diseases (NCDs) include:
Diabetes Health Status Report
A comprehensive global monitoring framework including indicators and a set of voluntary global targets for the prevention and control of NCDs Leanne Riley.
Dr Timothy Armstrong Coordinator
Presentation transcript:

The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine

The Global Burden of Non- Communicable Diseases (NCDs) 36/57 million (63%) global deaths in 2008 were due to NCDs: Cardiovascular diseases: 17 million Diabetes mellitus: 1.3 million Cancers: 7.6 million Chronic respiratory diseases: 4.2 million NCD deaths are expected to increase globally by 15% between 2010 and 2020

Major Causes of Global Mortality (WHO 2005) “Other conditions” comprises communicable diseases, maternal and perinatal conditions and nutritional deficiencies

The Burden of NCDs in the Developing World Nearly 80% of NCD deaths occur in middle and low income countries NCDs are most common cause of death in most countries (except Africa) In middle and low income countries 29% of NCD deaths occur in people below age 60, compared to 13% in high income countries Global status report on non-communicable diseases. WHO, 2010.

The Burden of NCDs in the Developing World Country Income LevelAge-standardized NCD mortality, males Age-standardized NCD mortality, females Middle/Low756/100,000565/100,000 High458/100,000307/100,000 % Difference65%85% Global status report on non-communicable diseases. WHO, 2010.

Total Death by Broad Cause Group, by WHO Region, World Bank Income Group, and by Gender, 2008

Proportion of Global NCD Deaths Under the Age of 70, by Cause of Death, 2008

Most Frequently Diagnosed Cancers by Country, Males, 2008

Most Frequently Diagnosed Cancers by Country, Females, 2008

Age-standardized Incidence Rates of All Cancers by Type of Cancer per 100,000 Population for Both Genders, by World Bank Income Groups, 2008

Age-standardized Prevalence of Diabetes in Adults Age 25+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Major Lifestyle Risk Factors Contributing to NCDs Globally Tobacco: 6 million deaths/year Insufficient physical activity: 3.2 million deaths/year Harmful use of alcohol: 2.3 million deaths/year Unhealthy diet: 2.8 million deaths/year from overweight/obesity

Age-standardized Prevalence of Daily Smoking in Adults 15+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Age-standardized Prevalence of Insufficient Physical Activity in Adults 15+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Total Adult (15+ Years of Age) Consumption of Pure Alcohol (liters) by Both Sexes, by WHO Region and World Bank Income Group, Projected Estimates, 2008

Availability of Total Fat and Saturated Fatty Acids (As% Dietary Energy Supply) for , by WHO Region and World Bank Income Group

Major Metabolic/Physiological Risk Factors Contributing to NCDs Globally Elevated BP: 7.5 million deaths/year Overweight/obesity: 2.8 million deaths/year Elevated cholesterol: 2.6 million deaths/year

Age-standardized Prevalence of Elevated Blood Pressure in Adults 25+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Age-standardized Prevalence of Overweight in Adults 20+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Age-standardized Prevalence of Obesity in Adults 20+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

Age-standardized Prevalence of Elevated Total Cholesterol in Adults 25+ Years, by WHO Region and World Bank Income Group, Comparable Estimates, 2008

“Best Buys” in Population-based Interventions to Prevent NCDs

“ Best Buys” in Individual-based Interventions to Prevent NCDs

Impact and Cost of Medical Interventions for Preventing Cardiovascular Disease in Developing Countries Multidrug regimen: a statin, ASA, and two antihypertensive medications, given in 23 developing countries Over 10 year period, 17.9 million deaths could be averted Annual cost: U$ for lower income countries, and U$ for middle income countries Sim SS et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007; 370: 2054–62.

The Vicious Cycle of Poverty and NCDs

The Importance of Primary Health Care in Prevention, Detection and Treatment of NCDs Integrated primary care vs. silos Importance of the primary health care team Importance of doctor/team/patient relationship over time Importance of basic diagnostic and treatment infrastructure

Availability of Laboratory Tests and Basic Technologies in Primary Care, by WHO Regions, 2010

Availability of Laboratory Tests and Basic Technologies in Primary Care, by World Bank Income Group, 2010

The Chronic Care Model Adapted with Permission from Wagner EH. Chronic Disease Management: What Will it Take to Improve Care for Chronic Illness? Effective Clinical Practice. 1998;vol. 1(1):2-4. Wagner EH. Chronic Disease Management: What Will it Take to Improve Care for Chronic Illness? Effective Clinical Practice. 1998;vol. 1(1):2-4.

References Except where noted otherwise, cited material comes from : Global status report on non-communicable diseases. WHO, 2010.

A 60 Year Old Woman With Hypertension BP 180/90. Asymptomatic. No obvious end organ damage Followed sporadically at Baylor Shoulder- to-Shoulder clinic in rural Honduras. Takes antihypertensive medications when she has them. Can’t afford to buy on her own How can she be maintained on chronic antihypertensive medication?

A 55 Year Old Woman With Type 2 Diabetes Mellitus Lives in poverty in rural Honduras BMI 26, active, walks several miles daily Limited food choices (beans and corn tortillas) Fasting FSBS 230 Current meds: sulfonylureas when she can get them No HbA1c, lipid panel, LFTs, urine microalbumin/creatinine tests available

What Are the Major Barriers to Preventing and Treating Chronic Diseases in Resource Poor Settings?

How Can These Barriers Be Overcome?

Implementing the Chronic Care Model in Your Practice: Clinical Practice Guidelines for Decision-support

Implementing the Chronic Care Model in Your Practice:Physician/Patient Reminders, Chronic Disease Registries Last Name, First Name Postal Address City, State, Zip Phone Number (H) Phone Number (W) Best call time Address (with patient’s permission) Primary Care Physician Date of last visit Key Clinical Data (below are examples, keep it simple) For Diabetes Date of last foot exam Date of last eye exam Last BP and date Last HbA1c and date Last LDL and date Latest Self Mgmt goal and date